700 patients110,866 observations180 daysLIVE
← Patients

Patient P-02403

Synthetic patientMETA-24 · Day 171 · 35–44 · M · baseline S03Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Stable
Discontinuation risk
20%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 started — Baseline state S03
  2. Day 30 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 30.

Primary contributors, last 14 days
  • Treatment adherence+10
  • Inflammatory activity-2
  • Nutritional resilience+2
  • Toxicity-2

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    13 min
    improving · +3.3 vs previous 14 d
    Sleep duration
    Wearable
    7.8 h
    stable · -0.2 vs previous 14 d
    Energy level
    Daily log
    6.3/10
    worsening · -0.4 vs previous 14 d
    Steps
    Wearable
    1,729
    improving · +182 vs previous 14 d
    GI burden
    Companion
    33/100
    worsening · +11.1 vs previous 14 d
    Adherence
    Companion
    95.7 %
    stable · +2.3 vs previous 14 d
    Sleep quality
    Wearable
    62.4/100
    worsening · -4.3 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    136 mg/dL
    worsening · +6.9 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 69 from the failing basin, 19 from restoration.

    Good elements to keep
    • Protein (supports)
      perturbation · steering +12.1
    • Butyrate producers intact
      hidden · steering +7.5
    • Daily walks resumed
      perturbation · steering +3.3
    • Protein
      supporter · GI -7 next day
    Main detractors to watch
    • FUT2 non-secretor
      hidden · steering -10.6
    • Histamine load
      perturbation · steering -9.6
    • Enterobacteriaceae elevated
      hidden · steering -7.4
    • Antibiotic course
      perturbation · steering -4.7
    • Histamine load
      detractor · GI +5.7 next day
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -7supporter · 95%
    • Histamine load
      +5.7detractor · 95%
    • Caffeine
      +2.6no signal · 48%
    • Alcohol
      -2.4no signal · 42%
    • Simple carbohydrates
      +1.6no signal · 30%
    • Dietary fat load
      +1.1no signal · 20%
    • Insoluble fibre
      -0.7no signal · 15%
    • Ultra-processed food
      +0.6no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Mucosal barrier integrity ↓60
      • DNAFUT2 non-secretor lowers mucosal fucosylation
      • MicrobiomeAkkermansia low → thinner mucus layer
    • Autonomic recovery ↑20
      • Wearable1,729 steps/day
    DNA
    Fictional pharmacogenomic panel
    • FUT2 rs601338 AA (non-secretor)
      Reduced mucosal fucosylation
    • CYP2D6 Normal metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 4.3 · butyrate capacity 66/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisNormal
    • Bifidobacterium longumLow
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    52 ms
    Sleep
    7.5 h
    Steps
    2,760
    Resting HR
    62 bpm
    Daily log: GI score 33, nutritional resilience 58, adherence 96.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Keep fibre steady; no new sources this week
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • A 15-minute walk after lunch
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0248346%S06BR-03no change64
    P-0228034%S07BR-03no change50
    P-0235444%S01CR-01improved78
    P-0249153%S09DT-01no change65
    P-0246250%S12DT-01improved65
    P-0251843%S17DT-01improved68
    P-0221837%S01DT-01improved61
    P-0223537%S14DT-01improved50
    P-0227436%S15DT-01improved50
    P-0233935%S03DT-01improved50
    P-0212634%S16DT-01improved59
    P-0233034%S15DT-01no change57